Related Experiment Video

Updated: Jul 5, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Comprehensive management of cardiometabolic risk factors

James Early1

  • 1Department of Preventive Medicine and Public Health, University of Kansas School of Medicine-Wichita, Wichita, Kansas 67214-3199, USA. eablah@kumc.edu

Clinical Cornerstone
|May 3, 2008
PubMed

Insights

Managing cardiometabolic risk involves assessing patient risk factors and utilizing tools like the Framingham Risk Score. Lifestyle changes and medication can prevent diabetes and cardiovascular disease progression.

Area of Science:

  • Cardiology
  • Endocrinology
  • Preventive Medicine

Background:

  • Cardiometabolic risk is a significant public health concern.
  • Effective management requires addressing underlying risk factors.
  • Early identification and intervention are crucial for preventing disease progression.

Purpose of the Study:

  • To outline a comprehensive approach to managing cardiometabolic risk.
  • To emphasize the importance of risk assessment tools and patient knowledge.
  • To highlight the role of lifestyle modification and pharmacotherapy.

Main Methods:

  • Utilizing formal risk assessment tools (e.g., Framingham Risk Score, National Cholesterol Education Program Adult Treatment Panel III).
  • Conducting a thorough patient risk assessment.
  • Implementing lifestyle modifications and pharmacotherapy.
  • Performing periodic reassessment of patient risk.

Main Results:

  • Formal risk assessment tools aid in initial treatment planning.
  • Lifestyle modification and pharmacotherapy show promise in delaying/preventing insulin resistance, diabetes, and cardiovascular disease.
  • Periodic risk reassessment guides long-term management strategies.

Conclusions:

  • Comprehensive cardiometabolic risk management is essential.
  • Risk assessment and patient knowledge are foundational to effective treatment.
  • Lifestyle interventions and pharmacotherapy are key to preventing disease progression and achieving optimal cardiometabolic health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...